Bristol-Myers Squibb Company Ce
NYSE: CELG-RI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Christopher S. Boerner
- Employees
- 34,100
- Headquarters
- Princeton, United States
- IPO year
- 2019
- Market cap
- $245.0M
- Website
- http://www.bms.com
Loading CELG-RI…
Loading profile data…Frequently asked questions about CELG-RI
What does Bristol-Myers Squibb Company Ce (CELG-RI) do?
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological pro...
Where does CELG-RI trade?
Bristol-Myers Squibb Company Ce (CELG-RI) trades on the New York Stock Exchange.
What sector is CELG-RI in?
Bristol-Myers Squibb Company Ce (CELG-RI) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Bristol-Myers Squibb Company Ce?
Christopher S. Boerner is the chief executive officer of Bristol-Myers Squibb Company Ce (CELG-RI).
Where is Bristol-Myers Squibb Company Ce headquartered?
Bristol-Myers Squibb Company Ce is headquartered in United States.
Does CELG-RI pay a dividend?
Bristol-Myers Squibb Company Ce (CELG-RI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CELG-RI go public?
Bristol-Myers Squibb Company Ce (CELG-RI) completed its initial public offering in 2019.